Abstract
A total of 48 haemodialysed patients were studied by radioimmunoassay for the serum concentrations of parathormone, calcitonin, gastrin, insulin, prolactin, T3, T4, rT3, TSH and cortisol. Residual urines were measured for cAMP and ultrafiltrates for iPTH and gastrin. The duration of the dialysis programme, the number of haemodialysis sessions per week, sex distribution, the dialysis alternatives (including haemofiltration, haemoperfusion) and successful kidney transplantations were correlated with the serum hormone levels. Significant increases in PTH gastrin and prolactin values were demonstrated in the dialysed patients. However, their calcitonin and insulin concentrations decreased, parallel with the time elapsed since the start of the haemodialysis programme (HDP). The number of dialysis sessions per week was found to affect the hormone concentrations diversely. In the course of hemofiltration and haemoperfusion some of the centrations diversely. In the course of haemofiltration and haemoperfusion some of the hormone levels (e.g. PTH, gastrin) decreased significantly. The patients were in general euthyroid.
One of them, on HDP for several years, developed clinical and laboratory signs indicative of hyperthyroidism. In a considerable proportion of the cases the results of the hormone studies (increased PTH, CT, cAMP) were consistent with secondary hyperparathyroidism.
Kidney transplantation was followed by a decline of the serum prolactin, parathormone, calcitonin and aldosterone levels.
Similar content being viewed by others
References
Balogh, F., Petrányi, Gy., Rényi-Vámos, F.: Nephrologia. Medicina, Budapest 1980.
Beckett G. J., Henderson, C. J., Elwes, R., Seth, J., Lambie, A. T.: Thyroid status in the patients with chronic renal failure.Clin. Nephrol., 19, 172 (1983).
Bonomini, V., Orsoni, I., Stefoni, S., Vangelista, A.: Hormonal changes in uremia.Clin. Nephrol., 11, 275 (1979).
Cold, C. H., Morley, J. E., Viljoen, M., On Tim, L., De Fomseca M., Kalk, W. J.: Gastric acid secretion and serum gastrin levels in patients with chronic renal failure on regular hemodialysis.Nephron, 25, 92 (1980).
Christiensen, C. K., Nielsen, H. E., Brandsborg, M., Bradsborg, O.: Increased serum gastrin concentration in hemodialysis patients treated with 1-alfa-hydroxy vitamin D3.Scand. J. Gastroenterol., 12, 967 (1977).
Cunningham, J., Segre, G. V., Statopolsky, E., Avioli, L. V.: Effect of histamin H2 receptor blockade on parathyroid status in normal and uraemic man.nephron, 38, 17 (1984).
Giordano, C.: Thyroid function during hemodialysis and CAPD. 4th ISAP Off. Stat. Symp. on CAPD 1984, Cleveland, p. 535.
Gurland, H. J., Castro, L. A., Samtleben, W., Fernandez, J. C.: Combination of hemodialysis and hemoperfusion in single unit for treatment of uremia.Clin. Nephrol., 11, 167 (1979).
Hershman, J. M., Krugman, L. G., Kopple, J. D., Reef, A. W., Azukiwa, M., Shinaberger, J. H.: Thyroid function in patients on maintenance hemodialysis: unexplained low serum thyroxine concentration.Metabolism, XXVII, 755 (1978).
Kokot, F.: the endocrine system in patients with acute renal failure.Proc. Eur. Dial. Transplant. Assoc., 18, 617 (1981).
Kokot, F.: Endokrinologische Veränderungen bei der chronischen Niereninsuffizienz. In: R. Schmicker, P. T. Fröhling, K.-H. Götz (eds): Konservative Therapie der chronischen Niereninsuffizienz. II. Arbeitstagung der Gesellschaft für Nephrologie der DDR, Lindow/Mark 1982, p. 8.
Kraiem, Z., Glaser, B., Rosenzweig, A., Scheinfeld, M., Ben-Ari, J.: A spot sample test for the estimation of urinary or nephrogenous, cAMP in the evaluation of parathyroid function.Nephron, 35, 264 (1983).
Kramer, P., Matthaei, D., Fuchs, C., Arnold, R., Ebert, P., McIntosh, C., Schauder, P., Schwin, G., Scheler, F., Udwig, H., Reichel, J., Spitteller, S.: Assessment of hormone loss through hemofiltration.Trans. Am. Soc. Artif. Intern. Organs, 2, 128 (1978).
Leusen, R., Neinders, A. E.: Cyclical changes in serum thyroid hormone concentrations related to hemodialysis: movement of hormone into and out of the extravascular space as a possible mechanism.Clin. Nephrol., 18, 193 (1982).
Löcsey, L., Kakuk, Gy., Szabó, T., Wórum, I., Nagy, Z., Leövey, A.: Hormonal aspects and therapy of renal osteodystrophy.Orv. Hetil., 121, 2121 (1980).
Löcsey, L., Lenkey, B., Kakuk, Gy., Leövey, A.: Hormonal changes in the course of the hemodialysis programme. Congress of the Association of Endocrinology and Metabolism, 7–10 October, 1984. Abstr. PS/VI-7.
Ory, S. J.: Clinical uses of “luteinizing hormone releasing hormone”,Fertil. Steril., 39 577 (1983).
Parathyroid hormones, calcium and vitamin D: In: F. H. Meyers, E. Jawetz, A. Glodfien (eds.): Lange Med. Publ., Los Altos, Calif. USA, 1980. Chapter 7, p. 369.
Quellhorst, E.: Folge erhöhter Elimination mittelmolekularer Substanzen: Depletion oder Regulation des Stoffwechsels. In: E. Streicher, W. Schoepe (eds): Die adaequate Dialyse. Springer Verlag, Berlin-Heidelberg-New York 1982, p. 201.
Schneider, H., Streicher, E., Hachmann, H., Chmiel, H., Mylius, U.: Clinical experience with hemofiltration.Proc. Eur. Dial. Transplant. Assoc. 14, 136 (1977).
Sherwood, J., Reinhard, D., Garcia, M.: Does cimetidine inhibit parathyroid hormone secretion?N. Engl. J. Med., 300, 200 (1979).
Szücs, J.: Human calcitonin, serum-phosphate, renal failure.Lancet, 1, 1108 (1974).
Szücs, J.: Calcitonin and uraemic bone dystrophy. Candidate's Thesis. Budapest 1977.
Szücs, J., Makó, J., Fehér, T., Györgyi, T., Szathmári, M.: Serum-prolactin, testosterone, dehydroepiandrosterone sulphate in haemodialysis patients with chronic renal failure.Orv. Hetil., 125, 1865 (1984).
Thysen, B., Gatz, M., Freeman, R., Alpert, B. E., Charytan, Ch.: Serum thyroid hormone levels in patients on continuous ambulatory peritoneal dialysis and regular hemodialysis.Nephron, 33, 49 (1983).
Wagner, P. K., Krause, U., Scharfe, Th., Beyer, J., Rothmund, M.: Effect of cimetidine on basal and histamine-induced secretion of parathyroid hormone in vitro.Nephron, 36, 89 (1984).
Weissel, M., Stummvoll, H. K.: Serum reverse triiodothyronine (3,3′-5′α-Triiodothyronine) in end-stage renal failure.Nephron, 28, 303 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Löcsey, L., Lenkey, Á. & Leövey, A. Hormonal changes in haemodialysed and in kidney-transplanted patients. International Urology and Nephrology 19, 201–213 (1987). https://doi.org/10.1007/BF02550474
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02550474